Yes, saying about the same, and you are right about not being a day/out thing like insulin. Also right about being accepted more by newer generation than old pharts like me LOL. Trying to buy a rather large amount down here but they won't give it up. I think the shorts saw a chance to drive it down this morning in a low volume situation. Good luck all
I just was stating my use of product and don't see a lot to be made on this product more so because of what insurance companies will cover. I still have to use syringe and vial for insulin as my insurance won't cover the newer injectable pens for insulin. And that is my point that with the way healthcare is going, it is trying to cut costs. I get vial and syringes free along with insulin through health insurance. If I use prefilled pens it costs me $26 a month. So my point comes down to what insurance companies will pay for. I just don't feel that glucagon is even worth bothering with because there are so many more innovative drugs coming that would be better served with mixable injectors. I definitely not putting UNIS down as I own many shares and have no problem waiting as things will work with this company. In fact I added another 10k yesterday @ $4.45 in morning.. I gave you a like as I like good discussion. Have a good day
No money to be made in glucagon. I don't call this as being a proprietary innovation. Might be a little simpler to use but it isn't that hard to mix the two components. You just inject solution from syringe into vial, mix it and draw out dosage. No rocket science and have had to do it many times. I will stick with doing it this way as I don't see this to be cost effective for "sugar and water". Eli Liily makes this kit. I don't think UNIS would waste their time on this low cost injectable.
I felt MDT and UNIS might have some type of relationship after reading this article as I use the Cardiocom that is made by MDT. Think about this possibility. With the Cardiocom they take measurements of many things. Say you had a heart problem that needs to be constantly monitored at home then you have a problem and you need a precise dosage of an injectable medication. The problem your having would be sent to a monitoring sight that decides what is wrong and how much of a dosage you would need then they would send out a signal to an injector you would wear and give precise dosage immediately. Technically it would be a return call to the Cardiocom, Which incidentally works via a cell phone signal. I use the Cardiocom to monitor my diabetes and when I am out of range I get a call from a nurse to take an injection. But this is my point, what if I could get the injection automatically by sending a signal to the injector. Just using this as an example. There will be a lot of great things coming from UNIS as I believe they are ahead of these types of innovations. I do feel something will be coming between MDT and UNIS. Time will tell. God luck
This was a short cover rally. Today's daily short sales were only 3455 shares. Never seen it this low before. I follow daily The only thing you can't tell by this is if it is being shorted for longer term or day trade. Yesterday was only 1400 shares and on Jan 25th it was 191893 shares. Lately it is the lowest I have seen daily short selling amounts. I don't make predictions and don't care if and when news comes out or why it is moving up. I am a patient long term holder.
I posted before I read it. I see it just relates to innovative medical devices which relates somewhat to UNIS. I guess that is why they put the article on their FB page. Sorry, almost legally blind and takes me time to read anything. I tried. TY for the thumbs down, the article sure didn't hurt anything.
wow. you made fun of me disposing of all my shares at 12.20 and told me good riddens. Buying at 2.10 and sold for 12 profit when I came to my senses. Good luck to you and I am also sitting on sidelines with this stock. Bought another stock and it is up 50% with this one down over 3 from where I sold it. Not in a rush to get back in now..
GROW UP. Your articles are fake with misspelling and miswording. Why be this way over a company that has potential You're just a con trader. Pump today, bash tomorrow with different ID. You've been doing the same on other boards under different IDs. Get lost.
The horses on this board all travel with blinders on. Like anybody's opinion on here is going to change what the stock does. You can't give any objective advice if it has a negative bent on here. Too much hyping and too much bashing. Most on here are truly weird.
These companies you keep mentioning are like trying to repair something with duct tape and wire instead of genuine parts
Here is 2 cents more for answering your post
These are kits made up from 3 different donors. Site says they last up to 4 weeks. They are limited to donor profiles and for testing only, not adding any kind of problems that a company might want to test. Very limited testing. Odd that a Princeton venture capital group that I know about is only 30 miles away from me. Princeton area big pharma area. Nice try again loser but put out all the info. With your lies and bits and pieces. This company a long way from made to order liver assays.
You say it already exists and the first sentence says to be developed. There is a big difference between 3D microcell that have to be viewed under a microscope and actual 3D printing of layers of tissue using a printer. You through this 3D word rather loosely around as none of these companies you mention are into 3D printing and have yet to be developed.
Only has to do with bone cells.
The results demonstrate distinct differences in the behavior of osteocytes when placed under alternative growth conditions. Unlike the growth of cells on conventional 2D culture plates, the 3D culture of Ocy454 cells using Alvetex®Scaffold technology recreates a more physiologically relevant niche microenvironment that more closely represents the physical surrounding cells experience in the native bone compartment. Moreover, the simulation of microgravity conditions using such models enables researchers to investigate and understand the molecular mechanisms that regulate bone formation and degradation. This will provide valuable insight into the consequences of unloading during time spent in microgravity environments and during extended periods of inactivity or bed-rest. Further experiments using these models and Alvetex®Scaffold technology are due to be conducted on board the International Space Station in 2014. KEEP TRYING LOSER
I partially lied. I only sold and bought back a portion of my holdings. I wasn't really completely out, but back to original amount. with an almost 18k gain from transaction and I'm the moron.